These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1490756)

  • 1. Variables associated with the assessment of systemic tumor necrosis factor alpha levels during hemodialysis.
    Jörres A; Froese P; Fischer C; Safak H; Gahl GM; Müller C; Vienken J
    Int J Artif Organs; 1992 Nov; 15(11):653-7. PubMed ID: 1490756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.
    Jörres A; Safak H; Froese P; Fischer C; Müller C; Gahl GM; Vienken J
    Artif Organs; 1992 Dec; 16(6):559-63. PubMed ID: 1482324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis.
    Arduino MJ; Bland LA; McAllister SK; Favero MS
    Artif Organs; 1995 Sep; 19(9):880-6. PubMed ID: 8687293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
    Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
    Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients.
    Caruana RJ; Lobel SA; Leffell MS; Campbell H; Cheek PL
    Int J Artif Organs; 1990 Dec; 13(12):794-8. PubMed ID: 2289831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions.
    Powell AC; Bland LE; Oettinger CW; McAllister SK; Oliver JC; Arduino MJ; Favero MS
    J Am Soc Nephrol; 1991 Nov; 2(5):1007-13. PubMed ID: 1760536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: relationship to endotoxins.
    Mege JL; Sanguedolce MV; Purgus R; Moulin B; Bongrand P; Capo C; Olmer M
    Am J Kidney Dis; 1992 Nov; 20(5):482-8. PubMed ID: 1279968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.
    Herbelin A; Nguyen AT; Zingraff J; Ureña P; Descamps-Latscha B
    Kidney Int; 1990 Jan; 37(1):116-25. PubMed ID: 2299797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Kidney Int; 1990 Jan; 37(1):85-93. PubMed ID: 2299810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material?
    Hoffmann U; Fischereder M; Marx M; Schweda F; Lang B; Straub RH; Krämer BK
    Am J Nephrol; 2003; 23(6):442-7. PubMed ID: 14583663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis.
    Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of tumor necrosis factor alpha during hemodialysis.
    Paydaş S; Aksu HS; Paydaş S; Karademir M; Gürçay AA
    Nephron; 1991; 57(4):477-8. PubMed ID: 2046832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.